New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Prelude Therapeutics Incorporated (PRLD) vs Q32 Bio Inc. (QTTB)
- Prelude Therapeutics Incorporated PRLD 3.23 −0.92%
- Q32 Bio Inc. QTTB 8.34 −1.65%
Prelude Therapeutics Incorporated and Q32 Bio Inc. are both Biotechnology companies. Prelude Therapeutics Incorporated and Q32 Bio Inc. are of similar size ($260.5M and $253.8M). Prelude Therapeutics Incorporated has negative trailing earnings, so its P/E is not meaningful; Q32 Bio Inc. trades at 2.5×. Q32 Bio Inc. has the higher net margin (808.0% vs −247.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Q32 Bio Inc. leads on 12 and Prelude Therapeutics Incorporated on 0.
Valuation
Profitability
| Metric | PRLD | QTTB | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 70.18% |
| Operating margin | (283.92%) | 725.53% | 0.00% |
| Net margin | (247.12%) | 808.04% | 0.00% |
| Free cash flow margin | (129.68%) | 280.89% | 0.00% |
| Return on equity | (58.36%) | 23.96% | (51.58%) |
| Return on assets | (39.45%) | 18.17% | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack